Overview
Legal name
INTERCYTEX LIMITED
Region
North West England
Registered address
Unknown
Insolvency history
No
Company
Active
LTD
Company profile
Intercytex Limited
Intercytex Limited is a UK company with status active founded in 1999 based in North West England.
CRN
03724051
Founded
1999
Age
24
Corporate ownership
Updated 06 Jun 2026 16:52
1 level
1 ultimate controller
1
Company
Active
LTD
Intercytex Limited
CRN 03724051
2
Direct and ultimate controller
Active
LTD
Regenerative Solutions Limited
CRN 07156747
Company events
Reference milestones and recent Companies House filing stream events.
1 event
25 Feb
1999
Incorporated
InceptionCompany registered at Companies House
Public funding
7 awards
First funded
2006
Funded years
2006, 2008, 2010, 2012, 2013
Age at first award
7 years
Projects
2013
Feasibility Studies
Lead participant
Feasibility of developing innovative processes to improve the manufacturing logistics of cell therapy
1 Jul 2013 to 30 Jun 2014
Awarded
£137,323
Total cost £183,098
Cell Therapies hold the promise to treat a great many diseases, however one limiting feature of providing a living cell therapy is the realtively short shelf life of the products. This project aims to test the feasibility of using two different, innovative process changes to extend this shelf life considerably which would greatly impact how Intercytex's, ...
2012
Collaborative R&D
Lead participant
Expandable Clinical Grade Human Feeder Cells for hESc Derivation
1 Apr 2012 to 31 Mar 2014
Awarded
£119,937
Total cost £207,118
We aim to generate an inexhaustible supply of immortalised clinical grade human dermal fibroblasts (hDFs) for derivation of cGMP hESc lines. Human Embryonic stem cells (hESc) have great potential for use in clinical therapies but current hESc lines have not been generated under conditions suitable for clinical use. We will exploit our successful TSB-funde...
2010
Fast Track
Lead participant
Phase II clinical trial to examine Allogeneic Fibroblast therapy for Epidermolysis Bullosa
1 Jul 2010 to 31 Mar 2011
Awarded
£162,613
Total cost £271,022
Awaiting Public Summary
2010
Fast Track
Lead participant
Towards the clinical examination of Allogeneic human dermal fibroblast therapy for scar contractures particularly in injured military service personnel
1 Jul 2010 to 31 Mar 2011
Awarded
£78,956
Total cost £131,594
Awaiting Public Summary
2010
Feasibility Studies
Lead participant
New clinically compatible system for hESc derivations
1 Jul 2010 to 31 Mar 2011
Awarded
£58,000
Total cost £103,691
Awaiting Public Summary
2008
Collaborative R&D
Lead participant
A PRESERVATION AND PACKAGING PLATFORM FOR CELL AND TISSUE BASED THERAPIES
1 Oct 2008 to 30 Sep 2011
Awarded
£285,269
Total cost £751,696
Awaiting Public Summary
2006
Collaborative R&D
Complete system for producing autologous cells for use in regenerative medicine
1 Oct 2006 to 31 Jul 2011
Awarded
£1,405,730
Total cost £3,199,655
Awaiting Public Summary
Product types
Collaborative R&D
Fast Track
Feasibility Studies